Page 45 - AIH-1-1

Artificial Intelligence in Health Digital and AI strategies for pharmaceutical industry

4.6. Pharmaceutical enterprises the protection of data contributed by pharmaceutical

For pharmaceutical logistics enterprises, the main enterprises and users has always been a crucial subject.
criterion for deciding whether to introduce AI into their It is of significance for Pakistan to improve and refine
existing production and operation systems is the degree the measures to ensure data privacy, but it is difficult to
to which integrating AI technology with their own ensure total data security when practitioners or patients in
business can improve cost-effectiveness. Pharmaceutical the pharmaceutical industry use new foreign technologies.
logistics enterprises can establish R&D teams and Nevertheless, the primary resolution entails expediting
strengthen cooperation with AI technology exporters to the progress of R&D, fostering the growth of pertinent
achieve breakthroughs in cutting-edge applications, such expertise, dismantling technological monopolies,
as autonomous driving, intelligent medical robots, and mitigating potential data security hazards, and safeguarding
drones. While looking for highly mature AI technologies the personal rights and interests of users.
for their business system from a wide range of currently
available technologies, it is recommended that enterprises 5.3. Lack of service platform construction
evaluate the application results based on small-scale pilot The trend in the development of the pharmaceutical
applications and optimize or promote them based on industry is digitization, convenience, and efficiency. As
actual results. Continuous experimentations allow for Japan focuses on building remote and precise medical
experience accumulation that is valuable for establishing services, achieving this goal requires efficient operation
AI technology application logic and system for an of service platforms and the rapid development of related
enterprise [30,31] . industries. At present, Pakistan needs more pharmaceutical

5. Challenges in pharmaceutical industry of enterprise service platforms, and certain areas are set to
be improved in terms of the integration and development
Pakistan of related industries. It is challenging to realize remote
5.1. Lack of digital technology and precise medical services if instant access to patient
electronic medical record data is not made possible and
The late start of digital construction in Pakistan’s
pharmaceutical industry has stalled the progress in the information given to the doctors, pharmaceutical
implementing digital transformation in the pharmaceutical companies, and patients is asymmetric.
[32]
industry . There are differences between pharmaceutical Still, a thorough resolution of these issues requires the
enterprises and medical institutions in terms of scale, assistance of robust interactive platforms and expeditious
scientific research level, talent training, and technological data transfer. The pharmaceutical business in Pakistan
development. Some enterprises and hospitals with larger has to expedite the process of transformation, construct
scales or higher levels have proposed corresponding a primary interactive platform, and incorporate complex
countermeasures for digital transformation. However, for development principles to secure significant progress in
other small and medium-sized enterprises and hospitals the future.
below Grade IIA, the primary medical information system
is still in the popularization and construction stages. 6. Conclusions
Small- and medium-sized enterprises are constrained The lifespan of a firm is contingent on its capacity
by data communication barriers in production and R&D to implement sustainability measures, which in turn
work and need mature digital means to support R&D contribute to its profitability. Cost-effective digital and AI
work. However, to truly achieve digital transformation, we solutions facilitate the achievement of flexibility, optimal
can learn from the US development path, quickly integrate resource utilization, and enhanced shareholder values
pharmaceutical enterprises and institutions with the and profitability. For the widespread application of AI
information industry, narrow the digital transformation technology in clinical medical diagnosis, medical industry
gap, and accelerate R&D at all levels. personnel and AI developers believe that AI technology
can promote innovation and reform in the medical
5.2. Security issues with medical data industry. Although many consumers are still in a wait-
From the perspective of the digital development of the EU and-see mode regarding “AI technology + healthcare,” it
pharmaceutical industry, data breach has always been a is perceivable to see any disruptive technology undergo a
potential risk in digital transformation. Creating and using lengthy development and application process before the
data are the essence of the transformation, but privacy market accepts it. The development and application of AI in
and security issues regarding pharmaceutical data are pharmaceutical logistics have broad prospects, effectively
always a challenge. In the context of digital transformation, promoting the continuous development of the medical

Volume 1 Issue 1 (2024) 39 https://doi.org/10.36922/aih.1486